CDKN2A and cancer: <b>Patients and Methods</b>: We examined 72 Mexican patients (14 probands from distinct families, 48 relatives, and 10 nonrelated probands) carrying the <i>CDKN2A</i> (c.146T>C) form three hereditary cancer centers between September 2023 and September 2025.